| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 103,003,801 | 113,390,024 | 87,107,176 | | Cost of Revenue | 80,506,654 | 88,654,336 | 68,751,154 | | | Gross Profit | 22,497,147 | 24,735,688 | 18,356,022 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 21,187,543 | 21,245,976 | 17,072,131 | | Non Recurring | 1,558,668 | 1,028,311 | 15,870 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (249,064) | 2,461,400 | 1,268,022 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (717,663) | 1,019,504 | 773,101 | | Earnings Before Interest And Taxes | (2,637,439) | 3,709,023 | 2,041,122 | | Interest Expense | 348,233 | 428,725 | 321,249 | | Income Before Tax | (2,985,671) | 3,280,298 | 1,719,873 | | Income Tax Expense | 5,204,065 | 2,748,846 | 1,383,919 | | Minority Interest | 80,165 | (1,118,514) | (614,746) | | | | Net Income From Continuing Ops | (8,109,571) | (587,063) | (278,792) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,109,571) | (587,063) | (278,792) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,109,571) | ($587,063) | ($278,792) |
|
1.48% Nasdaq 0.00%
Income Statement
